Explore 3 Stock Ideas & Industry Insights Download Free Report
Oxford BioDynamics Plc attracted strong investor attention after advancing approximately 10.53% during trading on 25 June 2026. The company ranked among the leading gainers on the FTSE AIM market as investors increasingly focused on businesses operating within precision medicine, molecular diagnostics and advanced healthcare …
Futura Medical plc attracted strong buying interest after its shares climbed approximately 15.38% during trading on 25 June 2026. The impressive rally reflected improving investor confidence in the company's long-term commercial prospects and its transition from a research-focused biotechnology company into a growing consumer …
Advanced Medical Solutions Group plc emerged as one of the strongest performers in the UK healthcare sector after its shares climbed approximately 16.42% during trading on 25 June 2026. The rally attracted considerable investor attention as healthcare stocks continued benefiting from their reputation for …
Proteome Sciences plc attracted significant investor attention after its shares climbed approximately 13.33% during trading on 25 June 2026. The strong performance placed the company among the leading healthcare gainers on the FTSE AIM market as investors increasingly rotated into innovative life sciences companies …
GSK plc attracted renewed investor attention after advancing1.72%during trading on25 June 2026, reinforcing its position as one of the leading defensive stocks within the FTSE 100. As uncertainty surrounding interest rates, geopolitics and global economic growth continues, investors increasingly favour healthcare companies capable of …
• Hikma Pharmaceuticals PLC (LSE:HIK) published a Total Voting Rights (TVR) notice on 1 June 2026 in compliance with DTR 5.6.1.
• Futura Medical remains focused on commercialising its flagship Eroxon product while expanding its sexual-health portfolio.
Immupharma (LSE: IMM) is reportedly drawing heavy investor attention as biotech buzz builds across retail share-chat boards.
OptiBiotix Health (LSE: OPTI) is drawing fresh attention across retail investor forums as chatter around its SweetBiotix sugar-replacement platform intensifies.
• LSE:GENF gained 6.19% on 25 June 2026, outperforming most FTSE AIM healthcare peers.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…